A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Clinical trial NCT01326871 · COMPLETED

Trial details

NCT number: NCT01326871
Sponsor: Altor BioScience
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Transitional Cell Carcinoma of Bladder Urethra Cancer Ureter Cancer Malignant Tumor of Renal Pelvis

Start date: 2011-09-06
Primary completion: 2016-04-11
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.